Highlights from

ISTH 2019

The International Society of Thrombosis and Haemostasis

SCROLL TO ARTICLES

Gene therapy for severe haemophilia A: first-in-human evidence of durable efficacy and safety over 3 years

Rivaroxaban vs SOC in children: low VTE recurrence risk and improved clot resolution without increased bleeding

Post-hoc analysis of the YEARS study provides new insights into home management of acute PE

GARFIELD-VTE: how does renal impairment affect VTE patients’ risk of major adverse outcomes?

Could machine learning improve upon the Wells score for DVT risk stratification?

Ticagrelor demonstrates bactericidal efficacy against Gram-positive bacteria, including MRSA and VRE

Top image: PhonlamaiPhoto

The content and interpretation of these conference highlights are the views and comments of the speakers/ authors.

Supported by